Angastiniotis, M, Modell, B, Englezos, P, Boulyjenkou, V. Prevention and control of hemoglobinopathies. Bulletin of the World Health Organization 1995; 73: 375–386Google Scholar

UK NSC & UK Joint Committee on Medical Genetics Statement on Genetic Carrier Testing; 2012.Google Scholar

Streetley, A, Latinovic, R, Hall, K, Henthorn, K. Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant hemoglobinopathies in England: screening results for 2005–7. Journal of Clinical Pathology 2009; 62: 26–30Google Scholar

NHS Sickle Cell and Thalassemia Screening Programmes/Sicke Cell Society. Sickle Cell Disease in Childhood: Standards and Guidelines for Clinical Care, 2nd edn. London: NHS Sickle Cell and Thalassaemia Screening Programme in partnership with the Sickle Cell Society; 2010.Google Scholar

Howard, J, Telfer, P. Sickle Cell Disease in Clinical Practice. London: Springer; 2015.CrossRefGoogle Scholar

Oteng-Ntim, E, Ayensah, B, Knight, M, Howard, J. Pregnancy outcome in patients with sickle cell disease in the UK – a national cohort study comparing sickle cell anemia (Hb SS) with Hb SC disease. British Journal of Hematology 2015; 169(1): 129–137.Google Scholar

Oteng-Ntim, E, Meeks, D, Seed, P. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis. Blood 2015; 125(21): 3316–3325.CrossRefGoogle ScholarPubMed

CEMACH. Why Mothers Die 2000–2002. The Sixth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press; 2004.Google Scholar

CEMACH. Saving Mothers’ Lives: Reviewing Maternal Deaths to make Motherhood Safer: 2003–2005. The Seventh Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press; 2007.Google Scholar

CMACE. Saving Mothers’ Lives: Reviewing Maternal Deaths to make Motherhood Safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. British Journal of Obstetrics and Gynaecology 2011; 118: 1–203CrossRefGoogle Scholar

MBRRACE-UK. Saving Lives, Improving Mothers’ Care. Lessons Learned to Inform Future Maternity Care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–2012. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2014.Google Scholar

NCEPOD. A Sickle Crisis? A Report of the National Confidential Enquiry into Patient Outcome and Death. London: NCEPOD; 2008.Google Scholar

Smith-Whitley, K. Reproductive issues in sickle cell disease. Blood 2014; 124(24), 3538–3543.Google Scholar

Sickle Cell Society. Pregnancy, contraception and fertility. In Standards for the Clinical Care of Adults with Sickle Cell Disease in the UK. London: Sickle Cell Society; 2008: pp. 59–68.Google Scholar

Royal College of Obstetricians and Gynecologists. Management of Sickle Cell Disease in Pregnancy. Green-Top Guideline No. 61. London: Royal College of Obstetricians and Gynecologists; 2011.Google Scholar

Royal College of Obstetricians and Gynecologists. Management of Beta Thalassemia in Pregnancy. Green-Top Guideline No. 66. London: Royal College of Obstetricians and Gynecologists; 2014.Google Scholar

Koshy, M, Burd, L, Wallace, D et al. Prophylactic red cell transfusion in pregnant patients with sickle cell disease. a randomised comparative study. New England Journal of Medicine 1998; 319: 1447–1452CrossRefGoogle Scholar

Howard, RJ, Tuck, SM, Pearson, TC. Pregnancy in sickle cell disease in the UK: results of a multicenter survey of the effect of prophylactic blood transfusion on maternal and fetal outcome. British Journal of Obstetrics and Gynecology 1995; 102(12): 947–951.CrossRefGoogle ScholarPubMed

Asma, S, Kozanoglu, I, Tarım, E et al. Prophylactic red blood cell exchange may be beneficial in the management of sickle cell disease in pregnancy. Transfusion 2015; 55: 36–44.Google Scholar

NICE. Sickle cell acute painful episode: management of an acute painful sickle cell episode in hospital. NICE Clinical Guideline 143, June 2012.Google Scholar

Howard, J Hart, N, Roberts-Harewood, M et al. Guideline on the management of Acute Chest Syndrome in Sickle Cell Disease. General Hematology Task Force of the British Committee for Standards in Hematology (BCSH); 2015.CrossRefGoogle Scholar

Seaman, CD, Yabes, J, Moore, CG, Ragni, MV. Venous thromboembolism in pregnant women with SCD: A retrospective database analysis. Thrombosis Research 2014; 134(6): 1249–1252.Google Scholar

Noubouossie, D, Key, NS. Sickle cell disease and venous thromboembolism in pregnancy and the puerperium. Thrombosis Research 2015; 135(S1): S46–S48.Google Scholar

Pintova, S, Cohen, HW, Billett, HH. Sickle cell trait: is there an increased VTE risk in pregnancy and the postpartum? PLoS One 2013; 8(5): 1–6.CrossRefGoogle ScholarPubMed

Royal College of Obstetricians and Gynecologists. Thrombosis and Embolism during Pregnancy and the Puerperium, Reducing the Risk. Green-Top Guideline No. 37a. London: Royal College of Obstetricians and Gynecologists; 2015.Google Scholar

Kabrhel, C, Mark Courtney, D, Camargo, CA Jr et al. Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism. Academic Emergency Medicine 2010; 17(6): 589–597.CrossRefGoogle ScholarPubMed

Royal College of Obstetricians and Gynecologists. Thromboembolic Disease in Pregnancy and the Puerperium: Acute Management. Green-Top Guideline No. 37b. London: Royal College of Obstetricians and Gynecologists; 2015.Google Scholar